Alliance between the Hospital del Mar Medical Research Institute and Chemotargets to accelerate the design of new cancer therapiesMay 28th, 2022
FiledMay 28th, 2022• The company Chemotargets –based in the Barcelona Science Park and a leader in in the global market as a provider of intelligence and drug design prediction platform– has signed a strategic agreement with the Hospital del Mar Medical Research Institute (IMIM) to discovery and development of new oncological therapies that respond to important unmet medical needs.